Status:
COMPLETED
Mobile Evidence-Based Smoking Cessation for Veterans Living With HIV (MESH)
Lead Sponsor:
VA Office of Research and Development
Conditions:
Human Immunodeficiency Virus
Smoking
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Smoking is a significant cause of damage to health and quality of life specifically for Veterans with human immunodeficiency virus (HIV). Smoking cessation interventions for this population are lackin...
Detailed Description
Although smoking is a significant cause of damage to health and quality of life specifically for Veterans with human immunodeficiency virus (HIV), smoking cessation interventions for this population a...
Eligibility Criteria
Inclusion
- VHA patient
- HIV positive serostatus
- currently smoking 7 cigarettes per week
- willing to complete study procedures. Exclusion criteria are:
Exclusion
- current hospitalization
- acute risk for suicide documented in the medical record
- inability to complete study procedures.
Key Trial Info
Start Date :
November 18 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 10 2021
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT04135937
Start Date
November 18 2019
End Date
November 10 2021
Last Update
July 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Durham VA Medical Center, Durham, NC
Durham, North Carolina, United States, 27705-3875